Loading the map…
Other professional, scientific and technical activities n.e.c. · Stevenage
Glaxosmithkline Intellectual Property (No.3)
Glaxosmithkline Intellectual Property (No.3) Limited
Private limited company registered in Stevenage, classed under “Other professional, scientific and technical activities n.e.c.”.
Headline figures
No figures yet.
This company's accounts are on file with Companies House, but we haven't extracted them yet. Once we do, its net assets, cash, reserves and any disclosed profit will appear here.
Timeline
Checked 2026-11-06
- AccountsAudit exemption subsidiary accounts made up to 31 December 2025
- AccountsConsolidated accounts of parent company for subsidiary company period ending 31/12/25
- FilingAudit exemption statement of guarantee by parent company for period ending 31/12/25 (and 5 more like it since 20 May 2021)
- AccountsNotice of agreement to exemption from audit of accounts for period ending 31/12/25
- AccountsAudit exemption subsidiary accounts made up to 31 December 2024
- AccountsConsolidated accounts of parent company for subsidiary company period ending 31/12/24
- AccountsNotice of agreement to exemption from audit of accounts for period ending 31/12/24
- DirectorsAppointment of Mrs Anna Mary Harcourt Fent as a director on 10 July 2025
- DirectorsTermination of appointment of Jemma-Louise Reynolds as a director on 27 June 2025
- DirectorsAppointment of Mrs Cristina Barcelo Iglesias as a director on 23 September 2024
- DirectorsDirector's details changed for Mrs Demet Gurunlu Russ on 15 July 2024
- DirectorsDirector's details changed for Mr Graham Paul Rivers on 11 September 2024
27 earlier
- DirectorsDirector's details changed for Mrs Jemma-Louise Reynolds on 11 September 2024
- DirectorsDirector's details changed for Mr Adam Walker on 11 September 2024
- DirectorsDirector's details changed for Mrs Demet Gurunlu Russ on 11 September 2024
- DirectorsDirector's details changed for The Wellcome Foundation Limited on 11 September 2024
- AccountsAudit exemption subsidiary accounts made up to 31 December 2023
- AccountsConsolidated accounts of parent company for subsidiary company period ending 31/12/23
- AccountsNotice of agreement to exemption from audit of accounts for period ending 31/12/23
- DirectorsTermination of appointment of Gregory Maxime Reinaud as a director on 24 July 2024
- AddressRegister inspection address has been changed (and 1 more like it since 9 June 2023)
- DirectorsAppointment of Mrs Demet Gurunlu Russ as a director on 25 June 2024
- DirectorsTermination of appointment of Jill Dawn Anderson as a director on 25 June 2024
- DirectorsAppointment of Mrs Jemma-Louise Reynolds as a director on 4 April 2024
- DirectorsAppointment of Mr Gregory Maxime Reinaud as a director on 30 January 2024
- DirectorsTermination of appointment of Ziba Shamsi as a director on 13 September 2023
- OwnershipChange of details for Glaxo Group Limited as a person with significant control on 6 June 2023
- AccountsAudit exemption subsidiary accounts made up to 31 December 2022
- AccountsConsolidated accounts of parent company for subsidiary company period ending 31/12/22
- AccountsNotice of agreement to exemption from audit of accounts for period ending 31/12/22
- DirectorsAppointment of Mr Graham Paul Rivers as a director on 18 July 2023
- DirectorsTermination of appointment of James Russell Wheatcroft as a director on 18 July 2023
- AddressRegistered office address changed from 980 Great West Road Brentford Middlesex TW8 9GS to Gsk Medicines Research Centre Gunnels Wood Road Stevenage SG1 2NY on 6 June 2023
- DirectorsAppointment of Ms Jill Anderson as a director on 1 March 2023
- DirectorsTermination of appointment of Jerome Charles Maurice Andries as a director on 1 March 2023
- DirectorsAppointment of Dr Ziba Shamsi as a director on 28 October 2022
- DirectorsTermination of appointment of Kate Sophie Priestman as a director on 28 October 2022
- AccountsAudit exemption subsidiary accounts made up to 31 December 2021
- AccountsConsolidated accounts of parent company for subsidiary company period ending 31/12/21
- Directors
From the Companies House filing history. Routine confirmation statements are left out, and a run of the same filing is shown once.
Questions people ask
›What does Glaxosmithkline Intellectual Property (No.3) do?
Private limited company registered in Stevenage, classed under “Other professional, scientific and technical activities n.e.c.”.
›How much turnover does Glaxosmithkline Intellectual Property (No.3) make?
Answered in the full report
›Is Glaxosmithkline Intellectual Property (No.3) profitable?
Glaxosmithkline Intellectual Property (No.3)'s profit isn't public: small companies may file without a profit and loss account.
›Who runs and owns Glaxosmithkline Intellectual Property (No.3)?
Its directors are Edinburgh Pharmaceutical Industries Limited, Cristina Barcelo Iglesias, Anna Mary Harcourt Fent, Demet Gurunlu Russ, Graham Paul Rivers and 3 more. Its owners are shown to subscribers.
›Where is Glaxosmithkline Intellectual Property (No.3) based?
Its registered office is Gsk Medicines Research Centre, Gunnels Wood Road, Stevenage, SG1 2NY, in Stevenage.
›When was Glaxosmithkline Intellectual Property (No.3) founded?
Glaxosmithkline Intellectual Property (No.3) Limited was incorporated on 24 July 2018.
›Is Glaxosmithkline Intellectual Property (No.3) still trading?
The register lists Glaxosmithkline Intellectual Property (No.3) Limited as active.